0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cyclic Peptide Compounds Market Research Report 2026
Published Date: 2026-04-18
|
Report Code: QYRE-Auto-10A16982
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cyclic Peptide Compounds Market Research Report 2024
BUY CHAPTERS

Global Cyclic Peptide Compounds Market Research Report 2026

Code: QYRE-Auto-10A16982
Report
2026-04-18
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cyclic Peptide Compounds Market

The global Cyclic Peptide Compounds market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cyclic Peptide Compounds competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Cyclic Peptide Compounds is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cyclic Peptide Compounds is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Cyclic Peptide Compounds include Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, Roche (Chugai Pharmabody Research), Biopharma PEG Scientific, Pfizer, AstraZeneca, Eli Lilly, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cyclic Peptide Compounds market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cyclic Peptide Compounds. The Cyclic Peptide Compounds market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cyclic Peptide Compounds market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cyclic Peptide Compounds manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cyclic Peptide Compounds Market Report

Report Metric Details
Report Name Cyclic Peptide Compounds Market
Segment by Type
  • Natural Cyclic Peptide
  • Synthetic Cyclic Peptide
by Application
  • Biopharmaceutical
  • Environmental Protection
  • Scientific Research
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, Roche (Chugai Pharmabody Research), Biopharma PEG Scientific, Pfizer, AstraZeneca, Eli Lilly, GenScript Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Cyclic Peptide Compounds manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Cyclic Peptide Compounds production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Cyclic Peptide Compounds consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Cyclic Peptide Compounds Market report?

Ans: The main players in the Cyclic Peptide Compounds Market are Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, Roche (Chugai Pharmabody Research), Biopharma PEG Scientific, Pfizer, AstraZeneca, Eli Lilly, GenScript Biotech

What are the Application segmentation covered in the Cyclic Peptide Compounds Market report?

Ans: The Applications covered in the Cyclic Peptide Compounds Market report are Biopharmaceutical, Environmental Protection, Scientific Research, Others

What are the Type segmentation covered in the Cyclic Peptide Compounds Market report?

Ans: The Types covered in the Cyclic Peptide Compounds Market report are Natural Cyclic Peptide, Synthetic Cyclic Peptide

1 Cyclic Peptide Compounds Market Overview
1.1 Product Definition
1.2 Cyclic Peptide Compounds by Type
1.2.1 Global Cyclic Peptide Compounds Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Natural Cyclic Peptide
1.2.3 Synthetic Cyclic Peptide
1.3 Cyclic Peptide Compounds by Application
1.3.1 Global Cyclic Peptide Compounds Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Biopharmaceutical
1.3.3 Environmental Protection
1.3.4 Scientific Research
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Cyclic Peptide Compounds Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Cyclic Peptide Compounds Production Estimates and Forecasts (2021–2032)
1.4.4 Global Cyclic Peptide Compounds Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Cyclic Peptide Compounds Production Market Share by Manufacturers (2021–2026)
2.2 Global Cyclic Peptide Compounds Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Cyclic Peptide Compounds, Industry Ranking, 2024 vs 2025
2.4 Global Cyclic Peptide Compounds Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Cyclic Peptide Compounds Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Cyclic Peptide Compounds, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Cyclic Peptide Compounds, Product Offerings and Applications
2.8 Global Key Manufacturers of Cyclic Peptide Compounds, Date of Entry into the Industry
2.9 Cyclic Peptide Compounds Market Competitive Situation and Trends
2.9.1 Cyclic Peptide Compounds Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Cyclic Peptide Compounds Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Cyclic Peptide Compounds Production by Region
3.1 Global Cyclic Peptide Compounds Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Cyclic Peptide Compounds Production Value by Region (2021–2032)
3.2.1 Global Cyclic Peptide Compounds Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Cyclic Peptide Compounds by Region (2027–2032)
3.3 Global Cyclic Peptide Compounds Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Cyclic Peptide Compounds Production Volume by Region (2021–2032)
3.4.1 Global Cyclic Peptide Compounds Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Cyclic Peptide Compounds by Region (2027–2032)
3.5 Global Cyclic Peptide Compounds Market Price Analysis by Region (2021–2026)
3.6 Global Cyclic Peptide Compounds Production, Value, and Year-over-Year Growth
3.6.1 North America Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021–2032)
4 Cyclic Peptide Compounds Consumption by Region
4.1 Global Cyclic Peptide Compounds Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Cyclic Peptide Compounds Consumption by Region (2021–2032)
4.2.1 Global Cyclic Peptide Compounds Consumption by Region (2021–2026)
4.2.2 Global Cyclic Peptide Compounds Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Cyclic Peptide Compounds Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Cyclic Peptide Compounds Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Cyclic Peptide Compounds Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Cyclic Peptide Compounds Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Cyclic Peptide Compounds Production by Type (2021–2032)
5.1.1 Global Cyclic Peptide Compounds Production by Type (2021–2026)
5.1.2 Global Cyclic Peptide Compounds Production by Type (2027–2032)
5.1.3 Global Cyclic Peptide Compounds Production Market Share by Type (2021–2032)
5.2 Global Cyclic Peptide Compounds Production Value by Type (2021–2032)
5.2.1 Global Cyclic Peptide Compounds Production Value by Type (2021–2026)
5.2.2 Global Cyclic Peptide Compounds Production Value by Type (2027–2032)
5.2.3 Global Cyclic Peptide Compounds Production Value Market Share by Type (2021–2032)
5.3 Global Cyclic Peptide Compounds Price by Type (2021–2032)
6 Segment by Application
6.1 Global Cyclic Peptide Compounds Production by Application (2021–2032)
6.1.1 Global Cyclic Peptide Compounds Production by Application (2021–2026)
6.1.2 Global Cyclic Peptide Compounds Production by Application (2027–2032)
6.1.3 Global Cyclic Peptide Compounds Production Market Share by Application (2021–2032)
6.2 Global Cyclic Peptide Compounds Production Value by Application (2021–2032)
6.2.1 Global Cyclic Peptide Compounds Production Value by Application (2021–2026)
6.2.2 Global Cyclic Peptide Compounds Production Value by Application (2027–2032)
6.2.3 Global Cyclic Peptide Compounds Production Value Market Share by Application (2021–2032)
6.3 Global Cyclic Peptide Compounds Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Bicycle Therapeutics
7.1.1 Bicycle Therapeutics Cyclic Peptide Compounds Company Information
7.1.2 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio
7.1.3 Bicycle Therapeutics Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Bicycle Therapeutics Main Business and Markets Served
7.1.5 Bicycle Therapeutics Recent Developments/Updates
7.2 Apellis Pharmaceuticals
7.2.1 Apellis Pharmaceuticals Cyclic Peptide Compounds Company Information
7.2.2 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio
7.2.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Apellis Pharmaceuticals Main Business and Markets Served
7.2.5 Apellis Pharmaceuticals Recent Developments/Updates
7.3 Merck
7.3.1 Merck Cyclic Peptide Compounds Company Information
7.3.2 Merck Cyclic Peptide Compounds Product Portfolio
7.3.3 Merck Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Merck Main Business and Markets Served
7.3.5 Merck Recent Developments/Updates
7.4 Bachem
7.4.1 Bachem Cyclic Peptide Compounds Company Information
7.4.2 Bachem Cyclic Peptide Compounds Product Portfolio
7.4.3 Bachem Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Bachem Main Business and Markets Served
7.4.5 Bachem Recent Developments/Updates
7.5 Novartis
7.5.1 Novartis Cyclic Peptide Compounds Company Information
7.5.2 Novartis Cyclic Peptide Compounds Product Portfolio
7.5.3 Novartis Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Novartis Main Business and Markets Served
7.5.5 Novartis Recent Developments/Updates
7.6 Roche (Chugai Pharmabody Research)
7.6.1 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Company Information
7.6.2 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio
7.6.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Roche (Chugai Pharmabody Research) Main Business and Markets Served
7.6.5 Roche (Chugai Pharmabody Research) Recent Developments/Updates
7.7 Biopharma PEG Scientific
7.7.1 Biopharma PEG Scientific Cyclic Peptide Compounds Company Information
7.7.2 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio
7.7.3 Biopharma PEG Scientific Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Biopharma PEG Scientific Main Business and Markets Served
7.7.5 Biopharma PEG Scientific Recent Developments/Updates
7.8 Pfizer
7.8.1 Pfizer Cyclic Peptide Compounds Company Information
7.8.2 Pfizer Cyclic Peptide Compounds Product Portfolio
7.8.3 Pfizer Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Pfizer Main Business and Markets Served
7.8.5 Pfizer Recent Developments/Updates
7.9 AstraZeneca
7.9.1 AstraZeneca Cyclic Peptide Compounds Company Information
7.9.2 AstraZeneca Cyclic Peptide Compounds Product Portfolio
7.9.3 AstraZeneca Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 AstraZeneca Main Business and Markets Served
7.9.5 AstraZeneca Recent Developments/Updates
7.10 Eli Lilly
7.10.1 Eli Lilly Cyclic Peptide Compounds Company Information
7.10.2 Eli Lilly Cyclic Peptide Compounds Product Portfolio
7.10.3 Eli Lilly Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Eli Lilly Main Business and Markets Served
7.10.5 Eli Lilly Recent Developments/Updates
7.11 GenScript Biotech
7.11.1 GenScript Biotech Cyclic Peptide Compounds Company Information
7.11.2 GenScript Biotech Cyclic Peptide Compounds Product Portfolio
7.11.3 GenScript Biotech Cyclic Peptide Compounds Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 GenScript Biotech Main Business and Markets Served
7.11.5 GenScript Biotech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Cyclic Peptide Compounds Industry Chain Analysis
8.2 Cyclic Peptide Compounds Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Cyclic Peptide Compounds Production Modes and Processes
8.4 Cyclic Peptide Compounds Sales and Marketing
8.4.1 Cyclic Peptide Compounds Sales Channels
8.4.2 Cyclic Peptide Compounds Distributors
8.5 Cyclic Peptide Compounds Customer Analysis
9 Cyclic Peptide Compounds Market Dynamics
9.1 Cyclic Peptide Compounds Industry Trends
9.2 Cyclic Peptide Compounds Market Drivers
9.3 Cyclic Peptide Compounds Market Challenges
9.4 Cyclic Peptide Compounds Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Cyclic Peptide Compounds Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cyclic Peptide Compounds Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Cyclic Peptide Compounds Production Capacity (Tons) by Manufacturers in 2025
 Table 4. Global Cyclic Peptide Compounds Production by Manufacturers (Tons), 2021–2026
 Table 5. Global Cyclic Peptide Compounds Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Cyclic Peptide Compounds Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Cyclic Peptide Compounds Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Cyclic Peptide Compounds, Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cyclic Peptide Compounds Production Value, 2025
 Table 10. Global Market Cyclic Peptide Compounds Average Price by Manufacturers (US$/kg), 2021–2026
 Table 11. Global Key Manufacturers of Cyclic Peptide Compounds, Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Cyclic Peptide Compounds, Product Offerings and Applications
 Table 13. Global Key Manufacturers of Cyclic Peptide Compounds, Date of Entry into the Industry
 Table 14. Global Cyclic Peptide Compounds Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Cyclic Peptide Compounds Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Cyclic Peptide Compounds Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Cyclic Peptide Compounds Production Value Market Share by Region (2021–2026)
 Table 19. Global Cyclic Peptide Compounds Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Cyclic Peptide Compounds Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Cyclic Peptide Compounds Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Cyclic Peptide Compounds Production (Tons) by Region (2021–2026)
 Table 23. Global Cyclic Peptide Compounds Production Market Share by Region (2021–2026)
 Table 24. Global Cyclic Peptide Compounds Production (Tons) Forecast by Region (2027–2032)
 Table 25. Global Cyclic Peptide Compounds Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Cyclic Peptide Compounds Market Average Price (US$/kg) by Region (2021–2026)
 Table 27. Global Cyclic Peptide Compounds Market Average Price (US$/kg) by Region (2027–2032)
 Table 28. Global Cyclic Peptide Compounds Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 29. Global Cyclic Peptide Compounds Consumption by Region (Tons), 2021–2026
 Table 30. Global Cyclic Peptide Compounds Consumption Market Share by Region (2021–2026)
 Table 31. Global Cyclic Peptide Compounds Forecasted Consumption by Region (Tons), 2027–2032
 Table 32. Global Cyclic Peptide Compounds Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 34. North America Cyclic Peptide Compounds Consumption by Country (Tons), 2021–2026
 Table 35. North America Cyclic Peptide Compounds Consumption by Country (Tons), 2027–2032
 Table 36. Europe Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 37. Europe Cyclic Peptide Compounds Consumption by Country (Tons), 2021–2026
 Table 38. Europe Cyclic Peptide Compounds Consumption by Country (Tons), 2027–2032
 Table 39. Asia Pacific Cyclic Peptide Compounds Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 40. Asia Pacific Cyclic Peptide Compounds Consumption by Region (Tons), 2021–2026
 Table 41. Asia Pacific Cyclic Peptide Compounds Consumption by Region (Tons), 2027–2032
 Table 42. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 43. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption by Country (Tons), 2021–2026
 Table 44. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption by Country (Tons), 2027–2032
 Table 45. Global Cyclic Peptide Compounds Production (Tons) by Type (2021–2026)
 Table 46. Global Cyclic Peptide Compounds Production (Tons) by Type (2027–2032)
 Table 47. Global Cyclic Peptide Compounds Production Market Share by Type (2021–2026)
 Table 48. Global Cyclic Peptide Compounds Production Market Share by Type (2027–2032)
 Table 49. Global Cyclic Peptide Compounds Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Cyclic Peptide Compounds Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Cyclic Peptide Compounds Production Value Market Share by Type (2021–2026)
 Table 52. Global Cyclic Peptide Compounds Production Value Market Share by Type (2027–2032)
 Table 53. Global Cyclic Peptide Compounds Price (US$/kg) by Type (2021–2026)
 Table 54. Global Cyclic Peptide Compounds Price (US$/kg) by Type (2027–2032)
 Table 55. Global Cyclic Peptide Compounds Production (Tons) by Application (2021–2026)
 Table 56. Global Cyclic Peptide Compounds Production (Tons) by Application (2027–2032)
 Table 57. Global Cyclic Peptide Compounds Production Market Share by Application (2021–2026)
 Table 58. Global Cyclic Peptide Compounds Production Market Share by Application (2027–2032)
 Table 59. Global Cyclic Peptide Compounds Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Cyclic Peptide Compounds Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Cyclic Peptide Compounds Production Value Market Share by Application (2021–2026)
 Table 62. Global Cyclic Peptide Compounds Production Value Market Share by Application (2027–2032)
 Table 63. Global Cyclic Peptide Compounds Price (US$/kg) by Application (2021–2026)
 Table 64. Global Cyclic Peptide Compounds Price (US$/kg) by Application (2027–2032)
 Table 65. Bicycle Therapeutics Cyclic Peptide Compounds Company Information
 Table 66. Bicycle Therapeutics Cyclic Peptide Compounds Specification and Application
 Table 67. Bicycle Therapeutics Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 68. Bicycle Therapeutics Main Business and Markets Served
 Table 69. Bicycle Therapeutics Recent Developments/Updates
 Table 70. Apellis Pharmaceuticals Cyclic Peptide Compounds Company Information
 Table 71. Apellis Pharmaceuticals Cyclic Peptide Compounds Specification and Application
 Table 72. Apellis Pharmaceuticals Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 73. Apellis Pharmaceuticals Main Business and Markets Served
 Table 74. Apellis Pharmaceuticals Recent Developments/Updates
 Table 75. Merck Cyclic Peptide Compounds Company Information
 Table 76. Merck Cyclic Peptide Compounds Specification and Application
 Table 77. Merck Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 78. Merck Main Business and Markets Served
 Table 79. Merck Recent Developments/Updates
 Table 80. Bachem Cyclic Peptide Compounds Company Information
 Table 81. Bachem Cyclic Peptide Compounds Specification and Application
 Table 82. Bachem Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 83. Bachem Main Business and Markets Served
 Table 84. Bachem Recent Developments/Updates
 Table 85. Novartis Cyclic Peptide Compounds Company Information
 Table 86. Novartis Cyclic Peptide Compounds Specification and Application
 Table 87. Novartis Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 88. Novartis Main Business and Markets Served
 Table 89. Novartis Recent Developments/Updates
 Table 90. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Company Information
 Table 91. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Specification and Application
 Table 92. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 93. Roche (Chugai Pharmabody Research) Main Business and Markets Served
 Table 94. Roche (Chugai Pharmabody Research) Recent Developments/Updates
 Table 95. Biopharma PEG Scientific Cyclic Peptide Compounds Company Information
 Table 96. Biopharma PEG Scientific Cyclic Peptide Compounds Specification and Application
 Table 97. Biopharma PEG Scientific Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 98. Biopharma PEG Scientific Main Business and Markets Served
 Table 99. Biopharma PEG Scientific Recent Developments/Updates
 Table 100. Pfizer Cyclic Peptide Compounds Company Information
 Table 101. Pfizer Cyclic Peptide Compounds Specification and Application
 Table 102. Pfizer Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 103. Pfizer Main Business and Markets Served
 Table 104. Pfizer Recent Developments/Updates
 Table 105. AstraZeneca Cyclic Peptide Compounds Company Information
 Table 106. AstraZeneca Cyclic Peptide Compounds Specification and Application
 Table 107. AstraZeneca Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 108. AstraZeneca Main Business and Markets Served
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Eli Lilly Cyclic Peptide Compounds Company Information
 Table 111. Eli Lilly Cyclic Peptide Compounds Specification and Application
 Table 112. Eli Lilly Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 113. Eli Lilly Main Business and Markets Served
 Table 114. Eli Lilly Recent Developments/Updates
 Table 115. GenScript Biotech Cyclic Peptide Compounds Company Information
 Table 116. GenScript Biotech Cyclic Peptide Compounds Specification and Application
 Table 117. GenScript Biotech Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 118. GenScript Biotech Main Business and Markets Served
 Table 119. GenScript Biotech Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Cyclic Peptide Compounds Distributors List
 Table 123. Cyclic Peptide Compounds Customers List
 Table 124. Cyclic Peptide Compounds Market Trends
 Table 125. Cyclic Peptide Compounds Market Drivers
 Table 126. Cyclic Peptide Compounds Market Challenges
 Table 127. Cyclic Peptide Compounds Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cyclic Peptide Compounds
 Figure 2. Global Cyclic Peptide Compounds Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cyclic Peptide Compounds Market Share by Type: 2025 vs 2032
 Figure 4. Natural Cyclic Peptide Product Picture
 Figure 5. Synthetic Cyclic Peptide Product Picture
 Figure 6. Global Cyclic Peptide Compounds Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Cyclic Peptide Compounds Market Share by Application: 2025 vs 2032
 Figure 8. Biopharmaceutical
 Figure 9. Environmental Protection
 Figure 10. Scientific Research
 Figure 11. Others
 Figure 12. Global Cyclic Peptide Compounds Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Cyclic Peptide Compounds Production Value (US$ Million), 2021–2032
 Figure 14. Global Cyclic Peptide Compounds Production Capacity (Tons), 2021–2032
 Figure 15. Global Cyclic Peptide Compounds Production (Tons), 2021–2032
 Figure 16. Global Cyclic Peptide Compounds Average Price (US$/kg), 2021–2032
 Figure 17. Cyclic Peptide Compounds Report Years Considered
 Figure 18. Cyclic Peptide Compounds Production Share by Manufacturers in 2025
 Figure 19. Global Cyclic Peptide Compounds Production Value Share by Manufacturers (2025)
 Figure 20. Cyclic Peptide Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Top 5 and Top 10 Global Players: Market Share by Cyclic Peptide Compounds Revenue in 2025
 Figure 22. Global Cyclic Peptide Compounds Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 23. Global Cyclic Peptide Compounds Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 24. Global Cyclic Peptide Compounds Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 25. Global Cyclic Peptide Compounds Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 26. North America Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 27. Europe Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 28. China Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 29. Japan Cyclic Peptide Compounds Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 30. Global Cyclic Peptide Compounds Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 31. Global Cyclic Peptide Compounds Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 32. North America Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 33. North America Cyclic Peptide Compounds Consumption Market Share by Country (2021–2032)
 Figure 34. U.S. Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 35. Canada Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 36. Europe Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 37. Europe Cyclic Peptide Compounds Consumption Market Share by Country (2021–2032)
 Figure 38. Germany Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 39. France Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 40. U.K. Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 41. Italy Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 42. Russia Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 43. Asia Pacific Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 44. Asia Pacific Cyclic Peptide Compounds Consumption Market Share by Region (2021–2032)
 Figure 45. China Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 46. Japan Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 47. South Korea Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 48. China Taiwan Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 49. Southeast Asia Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 50. India Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 51. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 52. Latin America, Middle East & Africa Cyclic Peptide Compounds Consumption Market Share by Country (2021–2032)
 Figure 53. Mexico Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 54. Brazil Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 55. Turkey Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 56. GCC Countries Cyclic Peptide Compounds Consumption and Growth Rate (Tons), 2021–2032
 Figure 57. Global Production Market Share of Cyclic Peptide Compounds by Type (2021–2032)
 Figure 58. Global Production Value Market Share of Cyclic Peptide Compounds by Type (2021–2032)
 Figure 59. Global Cyclic Peptide Compounds Price (US$/kg) by Type (2021–2032)
 Figure 60. Global Production Market Share of Cyclic Peptide Compounds by Application (2021–2032)
 Figure 61. Global Production Value Market Share of Cyclic Peptide Compounds by Application (2021–2032)
 Figure 62. Global Cyclic Peptide Compounds Price (US$/kg) by Application (2021–2032)
 Figure 63. Cyclic Peptide Compounds Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India